The smart pill might be a business school case study
Proteus Digital Health, an early adopter at the nexus of technology and medicine, has filed for bankruptcy, the latest turn in a cautionary tale for a nascent sector.
As STAT’s Rebecca Robbins reports, the bankruptcy filing comes on the heels of a lost partnership, sweeping layoffs, and a struggle to stay solvent. Proteus, once valued at $1.5 billion, is reorganizing to stay afloat as it tries to sell itself.
Things weren’t always so dire. In 2017, Proteus won a pioneering FDA approval for a so-called smart pill, equipped with sensors that could determine whether patients were following their prescriptions. But sales were sluggish, and Proteus’s ambitions to expand the use of its technology never took off.
Read more.
As STAT’s Rebecca Robbins reports, the bankruptcy filing comes on the heels of a lost partnership, sweeping layoffs, and a struggle to stay solvent. Proteus, once valued at $1.5 billion, is reorganizing to stay afloat as it tries to sell itself.
Things weren’t always so dire. In 2017, Proteus won a pioneering FDA approval for a so-called smart pill, equipped with sensors that could determine whether patients were following their prescriptions. But sales were sluggish, and Proteus’s ambitions to expand the use of its technology never took off.
Read more.
No hay comentarios:
Publicar un comentario